FREMONT, Calif. (AP) — FREMONT, Calif. (AP) — Alamar Biosciences Inc. (ALMR) on Monday reported a loss of $13.2 million in its second quarter.
The Fremont, California-based company said it had a loss of 22 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.
The biotech company focused on proteomics, the study and measurement of proteins in the body posted revenue of $29.4 million in the period.
Alamar expects full-year revenue in the range of $116 million to $120 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALMR at https://www.zacks.com/ap/ALMR
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
